Oral consumption of Garcinia kola(Bitter kola) lowers intraocular pressure.


Journal

Acta ophthalmologica
ISSN: 1755-3768
Titre abrégé: Acta Ophthalmol
Pays: England
ID NLM: 101468102

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 08 09 2019
accepted: 23 03 2020
pubmed: 11 4 2020
medline: 11 8 2021
entrez: 11 4 2020
Statut: ppublish

Résumé

Garcinia kola (bitter kola) is locally ingested across the West African subregion. It has ocular hypotensive effects similar to some commonly used glaucoma medications when administered topically. The study assessed the effect of oral ingestion of G. kola on intraocular pressure (IOP). A randomized, single-blind, placebo-controlled, cross-over design was used in this study. Forty-six healthy subjects, aged between 19 and 27 years were recruited and randomized into two groups (A and B). Subjects in group A ingested 100 mg/kg body weight bitter kola in a 200 ml solution on their first visit and group B ingested 200 ml of water. On the second visit, the order of treatment was reversed, IOP was measured at baseline and every 45 min interval for 135 min. The mean difference between the baseline and post-treatment IOP measurements were tested for statistical significance using repeated-measures analysis of variance (95% confidence intervals [CIs]). Mean IOP measurements decreased by 7.9, 18.2 and 20.6% at 45, 90 and 135 min, respectively, after G. kola treatment. The reduction, though variable across subjects, was statistically significant (F [2.13, 95.62] = 90.35, p < 0.0001) across the respective time points. Repetition of an identical protocol without G. kola caused clinically negligible changes in IOP. There was no statistically significant influence of gender or age in G. kola effect on IOP reading. Oral ingestion of G. kola lowered the intraocular pressure of healthy young adults by 21%. Such an effect may be of therapeutic benefit to patients with POAG or ocular hypertension in low-income settings.

Identifiants

pubmed: 32275352
doi: 10.1111/aos.14440
doi:

Substances chimiques

Ophthalmic Solutions 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1028-e1033

Informations de copyright

© 2020 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Références

Adefule-Ositelu AO, Adefule AK & Giwa MS (1996): Effect of Garcinia kola extract on the intraocular pressures and papillary diameters of laboratory animals’ eyes. Nig Qtr J Hosp Med 6: 242-249.
Adefule-Ositelu AO, Adefule AK, Dosa BO & Onyenefa PC (2004): Antifungal activities of garcinia kola extracts on purulent human ocular discharges in Lagos University Teaching Hospital, Lagos. Nig Q J Hosp Med 14: 112-114.
Adefule-Ositelu AO, Onakoya AO, Adefule AK & Dosa OS (2005): Comparative chromatographic analysis and pharmacodynamic activities of garcinia kola nut extracts. Nig Q J Hosp Med 15: 30-33.
Adefule-Ositelu AO, Adegbehingbe BO, Adefule AK, Adegbehingbe OO, Samaila E & Oladigbolu K (2010): Efficacy of Garcinia kola 0.5% aqueous eye drops in patients with primary open-angle glaucoma or ocular hypertension. Middle East Afr J Ophthalmol 17: 88.
Adegbehingbe OO, Adesanya SA, Idowu TO, Okimi OC, Oyelami OA & Iwalewa EO (2008): Clinical effects of Garcinia kola in knee osteoarthritis. J Orthop Surg Res 3: 34.
BBC (1999): BBC News | Health | Ebola cure hope.
Biliaminu S, Abdul A, Abdul RM & Ajani S (2016): Effects of acute consumption of Garcinia kola on hepatic enzymes in apparently well Nigerian Youths. J Proteomics Enzymol 5: 2-4.
Brucculeri M, Hammel T, Harris A, Malinovsky V & Martin B (1999): Regulation of intraocular pressure after water drinking. J Glaucoma 8: 111-116.
Davies R & Mohammed US (2013): Engineering properties of Bitter Kola Nuts and Shell as potentials for development processing machines. Int J Sci Res Environ Sci 1: 337-343.
Esimone CO, Nwafor SV, Okoli CO, Chah KF, Uzuegbu DB, Chibundu C, Eche MA & Adikwu MU (2002): In vivo evaluation of interaction between aqueous seed extract of Garcinia kola Heckel and ciprofloxacin hydrochloride. Am J Ther 9: 275-280.
Farombi EO (2011): Bitter kola (Garcinia kola) seeds and hepatoprotection. In: Nuts and Seeds in Health and Disease Prevention. Amsterdam: Elsevier 221-228.
Goldblum D, Garweg JG & Bohnke M (2000): Topical rivastigmine, a selective acetylcholinesterase inhibitor, lowers intraocular pressure in rabbits. J Ocul Pharmacol Ther 16: 29-35.
Goldmann H (1961): Weiterer beitrag zur applanationstonometrie. Ophthalmologica 141: 441-456.
Heckel E & Schlagdenhauffen F (1884): Some African kolas, in their botanical, chemical and therapeutical aspects. Am Pharm 56: 81-177.
Hussain RA, Owegby AG, Parimoo P & Waterman PG (1982): Kolanone, a novel polyisoprenylated benzophenone with antimicrobial properties from the fruit of Garcinia kola. Planta Med 44: 78-81.
Ijomone OM & Obi AU (2013): Kolaviron, isolated from Garcinia kola, inhibits acetylcholinesterase activities in the hippocampus and striatum of Wistar rats. Ann Neurosci 20: 42.
Iwu MM (2014): Handbook of African medicinal plants. Boca Raton, FL: Taylor & Francis Group.
Iwu M & Igboko O (1982): Flavonoids of Garcinia kola seeds. J Nat Prod 45: 650-651.
Kaufman PL & Barany EH (1976): Loss of acute pilocarpine effect on outflow facility following surgical disinsertion and retrodisplacement of the ciliary muscle from the scleral spur in the cynomolgus monkey. Invest Ophthalmol Vis Sci 15: 793-807.
Kronfeld PC (1975): Water drinking and outflow facility. Invest Ophthalmol Vis Sci 14: 49-52.
Leung EW, Medeiros FA & Weinreb RN (2008): Prevalence of ocular surface disease in glaucoma patients. J Glaucoma 17: 350-355.
Liu W-C & Lin MC (2009): Effect of eye-rubbing and breath-holding on corneal biomechanical properties and intraocular pressure. Invest Ophthalmol Vis Sci 50: 1757.
Malihi M & Sit AJ (2012): Effect of head and body position on intraocular pressure. Ophthalmology 119: 987-991.
Maňourová A, Leuner O, Tchoundjeu Z, Van Damme P, Verner V, Přibyl O & Lojka B (2019): Medicinal potential, utilization and domestication status of bitter kola (Garcinia kola Heckel) in West and Central Africa. Forests 10: 2-18.
Nagaraju M & Porciatti V (2008): Head-up tilt reduces IOP and improves abnormal PERG in DBA/2J glaucoma. Invest Ophthalmol Vis Sci 49: 1556.
Naiho AO & Ugwu AC (2009): Blood pressure reducing effect of bitter kola (Garcinia kola, Heckel) in Wistar rats. African J Biomed Res 12: 131-134.
Nwafor A & Ogheneaga IE (1992): Influence of Garcinia kola on in-vivo secretion of gastric acid. African J Pharmacol 22: 107-109.
Prum BE, Rosenberg LF, Gedde SJ et al. (2016): Primary open-angle glaucoma preferred practice pattern® guidelines. Ophthalmology 123: P41-P111.
Quigley HA & Broman AT (2006): The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90: 262-7.
Realini T, Barber L & Burton D (2002): Frequency of asymmetric intraocular pressure fluctuations among patients with and without glaucoma. Ophthalmology 109: 1367-1371.
Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP & Mariotti SP (2004): Global data on visual impairment in the year 2002. Bull World Health Organ 82: 844-851.

Auteurs

Alex A Ilechie (AA)

Department of Optometry and Vision Science, University of Cape Coast, Cape Coast, Ghana.

Mohammed M Jeduah (MM)

Department of Optometry and Vision Science, University of Cape Coast, Cape Coast, Ghana.

Carl H Abraham (CH)

Department of Optometry and Vision Science, University of Cape Coast, Cape Coast, Ghana.

Stephen Ocansey (S)

Department of Optometry and Vision Science, University of Cape Coast, Cape Coast, Ghana.

Emmanuel Abu (E)

Department of Optometry and Vision Science, University of Cape Coast, Cape Coast, Ghana.

Theophilus Okyere (T)

Department of Optometry and Vision Science, University of Cape Coast, Cape Coast, Ghana.

Obarijima Ngosaro (O)

Department of Optometry, Madonna University, Okija, Nigeria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH